Publication | Closed Access
Oral topotecan demonstrates clinical activity in relapsed non-small cell lung cancer. Results from an open-label, phase III study (387) comparing oral topotecan to intravenous docetaxel
15
Citations
0
References
2005
Year
MedicineMetronomic TherapyIntravenous DocetaxelPathologyClinical ActivityBronchial NeoplasmPhase Iii StudyCancer TreatmentOncologyRadiation OncologyCancer ResearchLung CancerMolecular OncologyRadiologyHealth Sciences
7017